(Q45002419)

English

Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

0 references

type 2 diabetes

0 references

Afschin Gandjour

2

object named as

Afschin Gandjour

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Charles Christian Adarkwah

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

International Journal of Technology Assessment in Health Care

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

62-70

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Evolution, risk factors, and prognostic implications of albuminuria in NIDDM.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Quality of life associated with diabetes mellitus in an adult population.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Diabetes-related morbidity and mortality in a national sample of U.S. elders

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

The cost burden of diabetes mellitus: the evidence from Germany--the CoDiM study

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

European comparison of costs and quality in the prevention of secondary complications in Type 2 diabetes mellitus (2000-2001).

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Effectiveness of a disease management programme for patients with type 2 diabetes mellitus and albuminuria in primary care - the PROSIT project (Proteinuria Screening and Intervention).

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Valuing health states: a comparison of methods.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

High prevalence of immuno-unreactive intact albumin in urine of diabetic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

21 January 2018

[Appraisal of resource use in the German health-care system from the perspective of the statutory health insurance]

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

7 January 2021

based on heuristic

inferred from DOI database lookup

Antihypertensive agents for preventing diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpreting, integrating, and individualizing evidence about the prevention of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0266462309990584

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0266462309990584

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45002419&oldid=2061582385"